Escolar Documentos
Profissional Documentos
Cultura Documentos
Hemoglobin 6.29 g/dL Protein (+) Past Health History Relevant to Present Illness:
Urinalysis
Macroscopic Result Microscopic Result
Color Yellow RBC numerous
Appearance Cloudy WBC 3–5
PH 5.0 Epithelial cells Few
Specific Gravity 1.020 Amorphous material Few
Protein Trace
Glucose Neg ( - ) Bacteria moderate
Blood Typing
Blood Type “B+”
RH Pos ( + )
Remarks:
HgSAg non-reactive
Cues/ Nursing Scientific Basis Outcome Nursing Rationale Evaluation
Evidences Diagnosis Criteria Intervention
Subjective Deficient After 6-8 hours - Assess vital - These changes in After 6-hours of
“Kusog kaayo fluid of nursing signs, noting low vital signs are nursing
ang akong volume r/t intervention, the blood pressure – associated with intervention, the
pagdugo nya active fluid patient will be severe fluid volume loss patient is able to:
mura na syag loss as able to: hypotension, and/ or
fresh blood, di evidenced rapid heartbeat, hypovolemia. - Patient
pareha anang by excessive - Maintain fluid and thready established the
sa normal vaginal volume at peripheral pulses. following vital
menstruation,” bleeding functional level signs:
as verbalized as evidenced by - Note changes in - These signsT
by the patient. stable vital usual mentation, indicate sufficient P
signs. behaviour, and dehydration toR
Objective: functional cause poor cerebral BP
Vital Signs - Verbalize abilities such as perfusion or can
T understanding confusion, falling, reflect the effect of - Verbalize
P of causative and dizziness. electrolyte understanding of
R factors and imbalance. causative factors
BP purpose of and purpose of
individual - Note complaints - These signs individual
therapeutic and physical signs indicate sufficient therapeutic
interventions associated with dehydration. interventions and
and dehydration such medications.
medications. as lack of
sweating, GOAL
dizziness, and PARTIALLY
confusion. MET
DRUG STUDY
Patient: C. M. L. Age: 38 years old Hospital No.: 000000000040740 Room No.: Gyne 3
DRUG STUDY
Patient: C. M. L. Age: 38 years old Hospital No.: 000000000040740 Room No.: Gyne 3
Generic: Ordered: Indication: CNS: dizziness, - Assess BP and - To be able to - Emphasize the
Losartan Alone or with other fatigue, headache, pulse frequently determine if importance of
agents in the insomnia, weakness during initial dose there are continuing to
Timing: management of adjustment and changes in take as directed,
Brand: hypertension. CV: chest pain, periodically during patient’s BP. even if feeling
Cozaar edema, hypotension therapy. well.
Duration: Mechanism of Action:
Blocks the EENT: nasal - Monitor - To determine - Take missed
vasoconstrictor and congestion frequency of compliance. doses as soon as
Classification: Other Forms: aldosterone- secreting refills. remembered if
Anti- effects of a angiotensin Endo: not almost time
hypertensive, II at various receptor hypoglycaemia, for next dose;
angiotensin II sites, including weight gain do not double
receptor vascular smooth dose.
antagonist muscle and the adrenal GI: diarrhea,
glands. abdominal pain, - Caution
dyspepsia, nausea patient to avoid
salt substitutes
GU: impaired renal containing
function potassium or
foods
F and E:hyperkalemia containing high
levels of
MS: back pain, potassium or
myalgia sodium unless
directed by
Misc.: angioedema, health care
fever professional.
- Warn patient
that drug may
cause dizziness.
- Instruct
patient to notify
health care
professional if
swelling of
face, eyes, lips,
or tongue or if
difficulty
swallowing or
breathing occur.
- Emphasize the
importance of
follow-up
exams to
evaluate
effectiveness of
medication.
Appendix E (IVF Study)
MATERNAL PATERNAL
LEGENDS
MALE
B.M. C.A. A.M.
FEMALE C.M.L.
PATIENT
DECEASED
ASTHMATIC
HYPERTENSIVE
LIVER
CANCER